Escalon Medical Corp.
ESMC · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.5% | -1.6% | 13.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.7% | 43% | 45% | 43% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 1.4% | -0.5% | 4.3% | 3.4% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 0.9% | -1% | 3.8% | 0.2% |
| EPS Diluted | 0.002 | -0.024 | 0.034 | 0.002 |
| % Growth | 108.4% | -170.9% | 1,304.2% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |